SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.35%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$396M
AUM Growth
+$396M
(+11%)
Cap. Flow
-$33.8M
Cap. Flow
% of AUM
-8.54%
Top 10 Holdings %
Top 10 Hldgs %
35.42%
Holding
254
New
59
Increased
32
Reduced
45
Closed
40
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$22.4M |
| 2 |
Exxon Mobil
XOM
|
$14.8M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
$10.6M |
| 4 |
Merck
MRK
|
$8.74M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$8M |
Top Sells
| 1 |
Tempest Therapeutics
TPST
|
$49.8M |
| 2 |
Lexicon Pharmaceuticals
LXRX
|
$40.7M |
| 3 |
AGN
Allergan plc
AGN
|
$33.8M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$24.7M |
| 5 |
MBLY
Mobileye N.V.
MBLY
|
$8.1M |
Sector Composition
| 1 | Healthcare | 57.32% |
| 2 | Energy | 8.8% |
| 3 | Technology | 1.44% |
| 4 | Communication Services | 1.02% |
| 5 | Industrials | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
26
DELISTED
Regulus Therapeutics
RGLS
| $3.78M | 0.14% | 344,667 +83,737 | +32% | +$918K |
|
27
Arbutus Biopharma
ABUS
$711M
| $3.62M | 0.13% | 305,351 +134,530 | +79% | +$1.6M |
|
28
Opko Health
OPK
$1.1B
| $3.59M | 0.13% | 223,126 +45,575 | +26% | +$733K |
|
29
Sangamo Therapeutics
SGMO
$157M
| $3.59M | 0.13% | 323,390 +63,649 | +25% | +$706K |
|
30
Quest Resource Holding
QRHC
$38.5M
| $3.31M | 0.12% | 3,068,192 +49,742 | +2% | +$53.7K |
|
|
NWBO
31
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $3.26M | 0.12% | +328,400 | New | +$3.26M |
|
32
Adverum Biotechnologies
ADVM
$64.6M
| $3.21M | 0.12% | 197,800 +142,857 | +260% | +$2.32M |
|
|
VXX
33
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $3.18M | 0.12% | +158,000 | New | +$3.18M |
|
|
THMO
34
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
| $3.15M | 0.12% | 3,706,516 -286,146 | -7% | -$243K |
|
35
Plus Therapeutics
PSTV
$45.3M
| $2.99M | 0.11% | +5,364,100 | New | +$2.99M |
|
|
ENDP
36
DELISTED
Endo International plc
ENDP
| $2.98M | 0.11% | 37,358 +11,367 | +44% | +$906K |
|
|
RIBT
37
DELISTED
RiceBran Technologies
RIBT
| $2.88M | 0.1% | 845,857 +74,558 | +10% | +$254K |
|
|
ALXN
38
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.87M | 0.1% | +15,895 | New | +$2.87M |
|
39
Ascendis Pharma
ASND
$11.8B
| $2.81M | 0.1% | 160,000 -34,023 | -18% | -$598K |
|
|
IMUC
40
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
| $2.77M | 0.1% | 5,871,816 -17,205 | -0.3% | -$8.12K |
|
|
CEMP
41
DELISTED
Cempra, Inc.
CEMP
| $2.73M | 0.1% | 79,553 -120,847 | -60% | -$4.15M |
|
|
BCLI
42
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $2.69M | 0.1% | 743,647 -665,890 | -47% | -$2.4M |
|
|
AGTC
43
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.65M | 0.1% | 172,427 +22,427 | +15% | +$344K |
|
|
44
Lexicon Pharmaceuticals
LXRX
$400M
| $2.57M | 0.09% | 318,775 -5,053,025 | -94% | -$40.7M |
|
45
Edwards Lifesciences
EW
$47.8B
| $2.54M | 0.09% | +17,815 | New | +$2.54M |
|
|
RXDX
46
DELISTED
Ignyta, Inc.
RXDX
| $2.48M | 0.09% | 164,100 -94,932 | -37% | -$1.43M |
|
|
GNCA
47
DELISTED
Genocea Biosciences, Inc.
GNCA
| $2.32M | 0.08% | 168,580 +68,580 | +69% | +$942K |
|
48
FibroGen
FGEN
$47.8M
| $2.31M | 0.08% | 98,100 +59,701 | +155% | +$1.4M |
|
|
GWPH
49
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.26M | 0.08% | 18,405 -34,371 | -65% | -$4.22M |
|
|
XTLB
50
XTL Biopharmaceuticals
XTLB
$10.8M
| $2.21M | 0.08% | 1,150,981 -160,472 | -12% | -$308K |
|